cancer
account
around
million
death
million
case
diseas
annual
character
abnorm
cell
growth
uncontrol
cell
divis
develop
cancer
take
place
year
encompass
multipl
genet
phenotyp
modif
cancer
remain
second
common
caus
mortal
cardiovascular
diseas
among
cancer
breast
cancer
second
common
cancer
global
lung
cancer
usa
breast
cancer
respons
cancer
found
women
make
one
fatal
diseas
current
convent
breast
cancer
treatment
involv
therapeut
regimen
surgic
resect
chemotherapi
radiotherapi
combin
surviv
rate
shown
improv
current
use
treatment
stratefi
due
seriou
sideeffect
multidrug
resist
nonselect
well
quick
remov
drug
system
circul
new
effect
safer
anticanc
drug
need
natur
product
alway
play
crucial
role
discoveri
anticanc
drug
mani
natur
occur
anticanc
drug
current
use
clinic
chemoprevent
involv
use
natur
occur
syntheticallysemisynthet
prepar
compound
interven
carcinogenesi
process
initi
advanc
stage
cancer
compound
actual
revers
inhibit
stop
process
carcinogenesi
plantbas
compound
terpenoid
flavonoid
phenol
compound
alkaloid
xanthon
coumarin
anthocyanin
carotenoid
etc
report
exhibit
potent
anticanc
activ
rang
cancer
cell
variou
vitro
vivo
experiment
model
compound
shown
exert
anticanc
effect
via
varieti
mechan
includ
cell
cycl
arrest
apoptosi
induct
inhibit
cell
prolifer
angiogenesi
modul
protein
express
variou
cell
signal
pathway
includ
pathway
etc
glycyrrhiza
glabra
import
medicin
plant
tremend
pharmacolog
activ
includ
neuroprotect
antimicrobi
anticanc
activ
though
sever
molecul
plant
evalu
pharmacolog
one
activ
constitu
glycyrrhizin
acid
evalu
breast
cancer
keep
view
role
play
natur
occur
compound
tremend
potenti
glycyrrhiza
glabra
anticanc
drug
discoveri
primari
object
current
research
work
studi
anticanc
effect
glycyrrhizin
acid
human
breast
cancer
cell
along
demonstr
effect
cell
cycl
phase
distribut
cancer
cell
migrat
modul
signal
pathway
current
studi
follow
drug
chemic
reagent
use
glycyrrhizin
acid
puriti
certifi
hplc
annexin
vfitc
propidium
iodid
procur
sigmaaldrich
st
loui
mo
usa
mtt
kit
purchas
roch
usa
rpmi
dulbecco
modifi
eagl
medium
dmem
obtain
gibco
brl
carlsbad
ca
usa
antibodi
akt
pakt
mtor
pmtor
gapdh
purchas
cell
signal
technolog
usa
human
breast
cancer
cell
line
suppli
institut
cell
biolog
chines
academi
scienc
shanghai
china
cell
well
maintain
rpmi
medium
contain
fb
antibiot
uml
penicillin
g
streptomycin
cytotox
efficaci
glycyrrhizin
acid
evalu
mtt
assay
colorimetr
assay
base
reduct
yellow
colour
mtt
succin
dehydrogenas
present
mitochondria
mtt
move
live
cell
get
reduc
insolubl
formazan
complex
cell
densiti
cellswel
seed
plate
incub
h
treat
differ
dose
glycyrrhizin
acid
differ
time
period
untreat
cell
kept
control
group
incub
cell
wash
pb
twice
mtt
solut
ad
whole
cell
cultur
incub
min
final
absorb
measur
nm
use
elisa
plate
reader
elx
biotek
instrument
usa
assay
cell
harvest
count
use
haemocytomet
cell
seed
cellswel
incub
h
cell
allow
attach
form
complet
monolay
cell
variou
dose
drug
glycyrrhizin
acid
ad
cell
cultur
follow
cell
incub
h
wash
pb
coloni
thu
form
fix
use
methanol
cell
stain
crystal
violet
min
count
use
light
microscop
induct
apoptosi
determin
annexin
vfitc
assay
describ
previous
human
breast
cancer
cell
seed
plate
cell
densiti
cell
per
ml
incub
h
treat
vari
dose
glycyrrhizin
acid
h
cell
harvest
via
trypsin
wash
pb
twice
resuspend
bind
buffer
compris
annexin
vfitc
propidium
iodid
ad
cell
cell
incub
min
dark
final
sampl
observ
flow
cytometri
bd
bioscienc
cell
cycl
analysi
use
flow
cytometri
human
breast
cancer
cell
seed
densiti
cellsml
incub
overnight
describ
previous
medium
substitut
fresh
dmem
contain
sever
concentr
glycyrrhizin
acid
incub
h
treat
untreat
cell
trypsin
wash
cold
pb
twice
fix
use
methanol
min
cell
wash
icecold
pb
stain
propidium
iodid
rnase
ad
min
final
cell
analys
use
facscalibur
flow
cytomet
facscalibur
bd
bioscienc
data
process
cell
cycl
analysi
softwar
modifit
plate
invas
assay
perform
evalu
effect
glycyrrhizin
acid
invas
tendenc
cell
matrigel
coat
appli
polyvinylpyrrolidonefre
polycarbon
filter
pore
size
mm
medium
contain
fb
ad
lower
chamber
upper
chamber
along
coat
filter
place
onto
lower
chamber
variou
dose
glycyrrhizin
acid
ad
cell
cultur
densiti
cell
per
well
cell
incub
min
cell
cultur
contain
drug
seed
onto
upper
chamber
incub
anoth
min
cell
fix
stain
crystal
violet
min
analys
light
microscop
glycyrrhizin
acidtr
cell
wash
twice
icecold
pb
extract
ripa
buffer
compos
mixtur
phosphat
inhibitor
proteas
inhibitor
cell
lysat
centrifug
g
min
protein
concentr
estim
use
biorad
protein
analys
protein
separ
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
transfer
nitrocellulos
membran
millipor
corpor
usa
membran
probe
specif
antibodi
overnight
wash
buffer
salin
incub
appropri
secondari
antibodi
h
band
visual
use
ecl
chemiluminesc
detect
kit
perkin
elmer
cetu
foster
citi
ca
usa
data
shown
mean
sd
student
ttest
perform
compar
untreat
control
glycyrrhizin
acidtr
group
differ
consid
statist
signific
pvalu
glycyrrhizin
acid
induc
potent
cytotox
effect
inhibit
coloni
form
tendenc
mtt
assay
well
clonogen
assay
reveal
glycyrrhizin
acid
figur
could
induc
signific
cytotox
effect
well
inhibitori
effect
coloni
format
result
depict
figur
show
glycyrrhizin
acid
led
concentrationdepend
well
timedepend
growth
inhibitori
effect
human
breast
cancer
cell
clonogen
assay
show
differ
dose
glycyrrhizin
acid
tendenc
inhibit
suppress
coloni
format
tendenc
breast
cancer
cell
also
observ
tendenc
natur
occur
compound
enhanc
increas
dosag
cell
expos
figur
b
thu
glycyrrhizin
acid
dual
effect
one
cell
viabil
anoth
coloni
format
order
evalu
mode
action
behind
cytotox
action
glycyrrhizin
acid
cancer
cell
experi
use
flow
cytometri
combin
annexin
vfitc
propidium
iodid
use
assay
use
demonstr
whether
drug
induc
apoptosi
extent
apoptosi
result
shown
figur
reveal
glycyrrhizin
acid
tendenc
induc
earli
apoptot
featur
cancer
cell
compar
control
group
glycyrrhizin
acidtr
cell
show
high
percentag
apop
effect
glycyrrhizin
acid
cell
cycl
phase
distribut
assess
flow
cytometri
use
propidium
iodid
probe
result
shown
figur
ad
reveal
glycyrrhizin
acid
tendenc
significantli
alter
distribut
variou
cell
cycl
phase
compar
untreat
control
cell
glycyrrhizin
acidtr
cell
dose
led
increas
phase
apoptot
cell
cell
cell
actual
apoptot
cell
lowest
dna
content
result
indic
glycyrrhizin
acid
result
induct
apoptosi
signific
extent
addit
percentag
cell
also
increas
dosag
glycyrrhizin
acid
increas
one
characterist
featur
breast
cancer
abil
undergo
metastasi
highli
invas
behaviour
therefor
experi
use
matrigel
assay
carri
demonstr
whether
glycyrrhizin
acid
could
suppress
cell
invas
human
breast
cancer
cell
result
show
compound
fact
led
dosedepend
inhibit
cell
invas
cell
compar
untreat
control
cell
glycyrrhizin
acidtr
cell
show
signific
suppress
cell
invas
result
shown
figur
b
percentag
cell
invas
decreas
control
cell
glycyrrhizin
acidtr
cell
respect
fact
glycyrrhizin
acid
could
modul
protein
express
signal
pathway
evalu
use
western
blot
assay
find
shown
figur
indic
interest
outcom
compar
untreat
control
cell
glycyrrhizin
acidtr
cell
show
concentrationdepend
downregul
mtor
pmtor
protein
also
show
downregul
protein
express
thu
may
conclud
glycyrrhizin
acid
induc
anticanc
apoptot
effect
via
signal
pathway
due
lack
effect
treatment
cancer
fatal
diseas
rate
second
common
caus
death
major
issu
limit
avail
chemotherapi
sever
side
effect
chemoresist
natur
product
due
fewer
side
effect
higher
pharmacolog
potenti
consid
import
target
develop
drug
glycyrrhiza
glabra
import
medicin
plant
consid
b
b
c
pmtor
gapdh
tremend
potenti
glycyrrhizin
acid
also
known
glycyrrhizin
triterpen
saponin
mostli
isol
root
glycyrrhiza
glabra
glycyrrhizin
acid
report
possess
variou
pharmacolog
effect
shown
inhibit
liver
cell
injuri
given
patient
suffer
chronic
viral
hepat
liver
cirrhosi
compound
also
shown
effect
treatment
autoimmun
hepat
glycyrrhizin
acid
also
report
exhibit
antiinflammatori
effect
antivir
effect
rang
virus
includ
sar
coronaviru
hiv
hepat
viru
hepat
b
viru
hepat
c
viru
howev
anticanc
activ
glycyrrhizin
acid
human
breast
cancer
cell
well
effect
cell
apoptosi
cell
cycl
arrest
cell
invas
akt
signal
pathway
report
far
best
knowledg
cell
cycl
arrest
apoptosi
induct
regard
effect
strategi
stop
uncontrol
cell
growth
elimin
cancer
cell
apoptosi
especi
act
protect
mechan
abolish
harm
damag
cell
prior
appear
malign
backdrop
present
studi
aim
evalu
antitumor
effect
glycyrrhizin
acid
natur
occur
triterpen
saponin
compound
human
breast
cancer
cell
also
studi
effect
compound
coloni
format
cell
cycl
phase
distribut
cell
invas
pathway
initi
mtt
assay
clonogen
assay
use
evalu
effect
glycyrrhizin
acid
cell
viabil
coloni
format
tendenc
show
compound
induc
potent
cytotox
effect
along
inhibit
coloni
format
efficaci
cell
result
agreement
previou
studi
sever
plantderiv
molecul
chrysophanol
caffeic
acid
report
exert
antitumor
effect
via
inhibit
coloni
format
furthermor
use
flow
cytometri
effect
drug
apoptosi
induct
studi
indic
glycyrrhizin
acid
induc
earli
late
apoptosi
cell
treatment
dose
glycyrrhizin
acid
percentag
apoptot
cell
increas
respect
cell
cycl
arrest
common
caus
growth
inhibit
determin
whether
effect
extract
involv
alter
cell
cycl
progress
cell
cycl
distribut
analysi
flow
cytometri
use
propidium
iodid
probe
use
studi
effect
compound
cell
cycl
progress
bind
water
solubl
dna
intercal
propidium
iodid
correl
amount
dna
within
given
cell
rel
content
dna
indic
distribut
popul
cell
throughout
cell
cycl
glycyrrhizin
acid
induc
cell
cycl
arrest
led
signific
increas
cell
dosedepend
manner
shown
glycyrrhizin
acid
could
inhibit
cancer
cell
invas
concentrationdepend
manner
find
promis
sinc
well
establish
breast
cancer
one
invas
cancer
glycyrrhizin
acid
could
inhibit
behaviour
final
effect
glycyrrhizin
acid
express
level
variou
protein
includ
mtor
pmtor
akt
studi
use
western
blot
assay
result
reveal
glycyrrhizin
acidtr
cell
exhibit
concentrationdepend
downregul
mtor
pmtor
protein
also
show
downregul
protein
express
conclus
glycyrrhizin
acid
inhibit
human
breast
cancer
cell
growth
inhibit
coloni
format
induc
apoptosi
cell
cycl
arrest
inhibit
cell
invas
target
signal
pathway
sever
compound
target
akt
pathway
promis
anticanc
agent
strongli
believ
glycyrrhizin
acid
may
prove
import
lead
molecul
howev
indepth
mechanist
studi
requir
author
declar
conflict
interest
